Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$4.84M Buy
142,922
+30,249
+27% +$972K 0.08% 293
2017
Q2
$3.59M Sell
112,673
-105,294
-48% -$3.32M 0.07% 338
2017
Q1
$7.08M Buy
217,967
+155,359
+248% +$4.9M 0.24% 55
2016
Q4
$1.93M Sell
62,608
-78,312
-56% -$2.39M 0.05% 589
2016
Q3
$4.53M Buy
140,920
+39,209
+39% +$1.31M 0.09% 286
2016
Q2
$3.4M Buy
101,711
+14,334
+16% +$457K 0.06% 445
2016
Q1
$2.46M Sell
87,377
-38,154
-30% -$1.09M 0.04% 580
2015
Q4
$3.85M Buy
125,531
+41,316
+49% +$1.3M 0.04% 629
2015
Q3
$2.51M Sell
84,215
-267,399
-76% -$8.57M 0.02% 933
2015
Q2
$11.2M Buy
351,614
+305,027
+655% +$9.94M 0.1% 234
2015
Q1
$1.54M Sell
46,587
-616,484
-93% -$19.6M 0.02% 1291
2014
Q4
$19.6M Buy
663,071
+150,722
+29% +$4.32M 0.12% 189
2014
Q3
$14.4M Sell
512,349
-414,222
-45% -$11.6M 0.07% 357
2014
Q2
$26.1M Buy
926,571
+393,985
+74% +$11.2M 0.12% 156
2014
Q1
$16.2M Buy
532,586
+244,528
+85% +$7.29M 0.09% 245
2013
Q4
$8.37M Sell
288,058
-14,229
-5% -$414K 0.04% 538
2013
Q3
$8.24M Sell
302,287
-89,906
-23% -$2.45M 0.05% 459
2013
Q2
$10.4M Buy
+392,193
New +$10.8M 0.06% 351

Other funds holding PFE

Spot Trading's PFE Position: Q3 2017 in Review

Spot Trading sold out of Pfizer (PFE) in Q3 2017, closing a stake of 41,298 shares — an estimated $1.33M sold.

Spot Trading first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $30.8M in Q2 2013. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Spot Trading reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
  • Spot Trading sold 41,298 Pfizer shares in Q3 2017, an estimated $1.33M.
  • Spot Trading first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • Spot Trading's Pfizer position peaked at $30.8M in Q2 2013.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.